8 results on '"Murínová L"'
Search Results
2. Is Dupuytren’s disease an occupational illness?
- Author
-
Murínová, L, primary, Perečinský, S, additional, Jančová, A, additional, Murín, P, additional, and Legáth, Ľ, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania
- Author
-
Santos, S. Eekhout, I. Voerman, E. Gaillard, R. Barros, H. Charles, M.-A. Chatzi, L. Chevrier, C. Chrousos, G.P. Corpeleijn, E. Costet, N. Crozier, S. Doyon, M. Eggesbø, M. Fantini, M.P. Farchi, S. Forastiere, F. Gagliardi, L. Georgiu, V. Godfrey, K.M. Gori, D. Grote, V. Hanke, W. Hertz-Picciotto, I. Heude, B. Hivert, M.-F. Hryhorczuk, D. Huang, R.-C. Inskip, H. Jusko, T.A. Karvonen, A.M. Koletzko, B. Küpers, L.K. Lagström, H. Lawlor, D.A. Lehmann, I. Lopez-Espinosa, M.-J. Magnus, P. Majewska, R. Mäkelä, J. Manios, Y. McDonald, S.W. Mommers, M. Morgen, C.S. Moschonis, G. Murínová, L. Newnham, J. Nohr, E.A. Andersen, A.-M.N. Oken, E. Oostvogels, A.J.J.M. Pac, A. Papadopoulou, E. Pekkanen, J. Pizzi, C. Polanska, K. Porta, D. Richiardi, L. Rifas-Shiman, S.L. Roeleveld, N. Santa-Marina, L. Santos, A.C. Smit, H.A. Sørensen, T.I.A. Standl, M. Stanislawski, M. Stoltenberg, C. Thiering, E. Thijs, C. Torrent, M. Tough, S.C. Trnovec, T. Van Gelder, M.M.H.J. Van Rossem, L. Von Berg, A. Vrijheid, M. Vrijkotte, T.G.M. Zvinchuk, O. Van Buuren, S. Jaddoe, V.W.V.
- Abstract
Background: Gestational weight gain differs according to pre-pregnancy body mass index and is related to the risks of adverse maternal and child health outcomes. Gestational weight gain charts for women in different pre-pregnancy body mass index groups enable identification of women and offspring at risk for adverse health outcomes. We aimed to construct gestational weight gain reference charts for underweight, normal weight, overweight, and grades 1, 2 and 3 obese women and to compare these charts with those obtained in women with uncomplicated term pregnancies. Methods: We used individual participant data from 218,216 pregnant women participating in 33 cohorts from Europe, North America, and Oceania. Of these women, 9065 (4.2%), 148,697 (68.1%), 42,678 (19.6%), 13,084 (6.0%), 3597 (1.6%), and 1095 (0.5%) were underweight, normal weight, overweight, and grades 1, 2, and 3 obese women, respectively. A total of 138, 517 women from 26 cohorts had pregnancies with no hypertensive or diabetic disorders and with term deliveries of appropriate for gestational age at birth infants. Gestational weight gain charts for underweight, normal weight, overweight, and grade 1, 2, and 3 obese women were derived by the Box-Cox t method using the generalized additive model for location, scale, and shape. Results: We observed that gestational weight gain strongly differed per maternal pre-pregnancy body mass index group. The median (interquartile range) gestational weight gain at 40 weeks was 14.2 kg (11.4-17.4) for underweight women, 14.5 kg (11.5-17.7) for normal weight women, 13.9 kg (10.1-17.9) for overweight women, and 11.2 kg (7.0-15.7), 8.7 kg (4.3-13.4) and 6.3 kg (1.9-11.1) for grades 1, 2, and 3 obese women, respectively. The rate of weight gain was lower in the first half than in the second half of pregnancy. No differences in the patterns of weight gain were observed between cohorts or countries. Similar weight gain patterns were observed in mothers without pregnancy complications. Conclusions: Gestational weight gain patterns are strongly related to pre-pregnancy body mass index. The derived charts can be used to assess gestational weight gain in etiological research and as a monitoring tool for weight gain during pregnancy in clinical practice. © 2018 The Author(s).
- Published
- 2018
4. Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania
- Author
-
Santos, S., Eekhout, I., Voerman, I., Gaillard, R., Barros, H., Charles, M.-A., Chatzi, L., Chevrier, C., Chrousos, G.P., Corpeleijn, E., Costet, N., Crozier, S., Doyon, M., Eggesbø, M., Fantini, M.P., Farchi, S., Forastiere, F., Gagliardi, L., Georgiu, V., Godfrey, K.M., Gori, D., Grote, V., Hanke, W., Hertz-Picciotto, I., Heude, B., Hivert, M.-F., Hryhorczuk, D., Huang, R.-C., Inskip, H., Jusko, T.A., Karvonen, A.M., Koletzko, B., Küpers, L.K., Lagström, H., Lawlor, D.A., Lehmann, Irina, Lopez-Espinosa, M.-J., Magnus, P., Majewska, R., Mäkelä, J., Manios, Y., McDonald, S.W., Mommers, M., Morgen, C.S., Moschonis, G., Murínová, L., Newnham, J., Nohr, E.A., Nybo Andersen, A.-M., Oken, E., Oostvogels, A.J.J.M., Pac, A., Papadopoulou, E., Pekkanen, J., Pizzi, C., Polanska, K., Porta, D., Richiardi, L., Rifas-Shiman, S.-L., Roeleveld, N., Santa-Marina, L., Santos, A.C., Smit, H.A., Sørensen, T.I.A., Standl, M., Stanislawski, M., Stoltenberg, C., Thiering, E., Thijs, C., Torrent, M., Tough, S.C., Trnovec, T., van Gelder, M.M.H.J., van Rossem, L., von Berg, A., Vrijheid, M., Vrijkotte, T.G.M., Zvinchuk, O., van Buuren, S., Jaddoe, V.W.V., Santos, S., Eekhout, I., Voerman, I., Gaillard, R., Barros, H., Charles, M.-A., Chatzi, L., Chevrier, C., Chrousos, G.P., Corpeleijn, E., Costet, N., Crozier, S., Doyon, M., Eggesbø, M., Fantini, M.P., Farchi, S., Forastiere, F., Gagliardi, L., Georgiu, V., Godfrey, K.M., Gori, D., Grote, V., Hanke, W., Hertz-Picciotto, I., Heude, B., Hivert, M.-F., Hryhorczuk, D., Huang, R.-C., Inskip, H., Jusko, T.A., Karvonen, A.M., Koletzko, B., Küpers, L.K., Lagström, H., Lawlor, D.A., Lehmann, Irina, Lopez-Espinosa, M.-J., Magnus, P., Majewska, R., Mäkelä, J., Manios, Y., McDonald, S.W., Mommers, M., Morgen, C.S., Moschonis, G., Murínová, L., Newnham, J., Nohr, E.A., Nybo Andersen, A.-M., Oken, E., Oostvogels, A.J.J.M., Pac, A., Papadopoulou, E., Pekkanen, J., Pizzi, C., Polanska, K., Porta, D., Richiardi, L., Rifas-Shiman, S.-L., Roeleveld, N., Santa-Marina, L., Santos, A.C., Smit, H.A., Sørensen, T.I.A., Standl, M., Stanislawski, M., Stoltenberg, C., Thiering, E., Thijs, C., Torrent, M., Tough, S.C., Trnovec, T., van Gelder, M.M.H.J., van Rossem, L., von Berg, A., Vrijheid, M., Vrijkotte, T.G.M., Zvinchuk, O., van Buuren, S., and Jaddoe, V.W.V.
- Abstract
BackgroundGestational weight gain differs according to pre-pregnancy body mass index and is related to the risks of adverse maternal and child health outcomes. Gestational weight gain charts for women in different pre-pregnancy body mass index groups enable identification of women and offspring at risk for adverse health outcomes. We aimed to construct gestational weight gain reference charts for underweight, normal weight, overweight, and grades 1, 2 and 3 obese women and to compare these charts with those obtained in women with uncomplicated term pregnancies.MethodsWe used individual participant data from 218,216 pregnant women participating in 33 cohorts from Europe, North America, and Oceania. Of these women, 9065 (4.2%), 148,697 (68.1%), 42,678 (19.6%), 13,084 (6.0%), 3597 (1.6%), and 1095 (0.5%) were underweight, normal weight, overweight, and grades 1, 2, and 3 obese women, respectively. A total of 138, 517 women from 26 cohorts had pregnancies with no hypertensive or diabetic disorders and with term deliveries of appropriate for gestational age at birth infants. Gestational weight gain charts for underweight, normal weight, overweight, and grade 1, 2, and 3 obese women were derived by the Box-Cox t method using the generalized additive model for location, scale, and shape.ResultsWe observed that gestational weight gain strongly differed per maternal pre-pregnancy body mass index group. The median (interquartile range) gestational weight gain at 40 weeks was 14.2 kg (11.4–17.4) for underweight women, 14.5 kg (11.5–17.7) for normal weight women, 13.9 kg (10.1–17.9) for overweight women, and 11.2 kg (7.0–15.7), 8.7 kg (4.3–13.4) and 6.3 kg (1.9–11.1) for grades 1, 2, and 3 obese women, respectively. The rate of weight gain was lower in the first half than in the second half of pregnancy. No differences in the patterns of weight gain were observed between cohorts or countries. Similar weight gain pat
- Published
- 2018
5. Is Ionized Oxygen Negatively or Positively Charged More Effective for Carboxyhemoglobin Reduction Compare to Medical Oxygen at Atmospheric Pressure?
- Author
-
PEREČINSKÝ, S., primary, KRON, I., additional, ENGLER, I., additional, MURÍNOVÁ, L., additional, DONIČ, V., additional, VARGA, M., additional, MAROSSY, A., additional, and LEGÁTH, Ľ., additional
- Published
- 2015
- Full Text
- View/download PDF
6. Changes in occupational asthma during four decades in Slovakia, Central Europe.
- Author
-
Perečinský S, Murínová L, Kalanin P, Jančová A, and Legáth Ľ
- Subjects
- Adult, Asthma, Occupational etiology, Asthma, Occupational history, Female, History, 20th Century, History, 21st Century, Humans, Male, Middle Aged, Occupational Exposure history, Occupational Exposure statistics & numerical data, Slovakia epidemiology, Asthma, Occupational epidemiology, Occupational Exposure adverse effects
- Abstract
Introduction: Occupational asthma (OA) is the most common occupational lung disease in industrialized countries; however, in Western Europe, a decline in the prevalence of OA and changes in etiological factors has been recorded. Data from Central Europe, where in the past healthcare and economy sectors were different, are rare., Objective: The aim of this study was to discover the changes related to OA during a four decade long period in the Slovak Republic., Material and Methods: The study included patients whom OA was reported during 1980-2016. All cases of OA were divided into four decades. The prevalence of OA, changes in etiological factors and key diagnostic methods were evaluated. All decades were analysed separately and compared to one another., Results: During 1980-2016, OA was reported in 155 patients. OA was most often found in the second decade (6.4 cases per year), the lowest number of cases was diagnosed in the third decade (2.1 cases per year). Since 1988, an increasing prevalence of OA was observed with the peak in 1992, followed by the significantly progressive decrease during subsequent years. In the fourth decade, a mild increase in OA causes was recorded again. In the first and second decades, agricultural allergens were the dominant agents, which were replaced by chemical factors in the last decade. The most frequently used key diagnostic methods in 1980-2009 were skin tests, during the fourth decade the importance of this method declined. However, specific BPT a serial BPT were more frequently used in the fourth decade., Conclusion: The number of OA cases induced by agricultural allergens declined, which was connected with a decrease of total OA cases. The current problem is the OA induced by the chemicals, which increased significantly in the last decade, even the possibility of underdiagnosed OA cases still exists.
- Published
- 2018
- Full Text
- View/download PDF
7. Duration of breastfeeding and serum PCB 153 concentrations in children.
- Author
-
Lancz K, Hertz-Picciotto I, Jusko TA, Murínová L, Wimmerová S, Sovčíková E, Dedík L, Strémy M, Drobná B, Farkašová D, and Trnovec T
- Subjects
- Adult, Child, Female, Humans, Breast Feeding, Polychlorinated Biphenyls blood
- Abstract
Polychlorinated biphenyls (PCBs) are toxic, persistent, and bioaccumulative chemicals which, because of their lipophilic properties, are abundant in human breast milk. Breastfed infants are therefore at risk of being exposed to considerable amounts of PCBs. The commonly used exposure estimations, based solely on breast milk PCB levels and duration of breastfeeding, may lead to exposure misclassification. To improve assessments of exposure to PCBs, we determined PCB 153 serum concentration, as a model substance for PCBs, at the critical time of weaning for each child in 305 breastfed infants from 5 single time point concentration measurements spread over 7 years and data on duration of breastfeeding, using an earlier developed model of the system type. We approximated the dependence of PCB 153 serum concentration, Ctbf, adjusted to cord serum concentration, C0, on nursing period, by a polynomial function Ctbf/C0=0.596+0.278t-0.0047t(2) which reliably predicts exposure to PCB 153 of breastfed infants, important for assessment of dose-outcome relationships. Adjustment of current serum concentrations to cord serum concentration improved validity of exposure assessment., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
8. Effects of partially ionised medical oxygen, especially with O2•-, in vibration white finger patients.
- Author
-
Perečinský S, Murínová L, Engler I, Donič V, Murín P, Varga M, and Legáth L
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Occupational Diseases, Raynaud Disease therapy, Air Ionization, Hand-Arm Vibration Syndrome therapy, Oxygen Inhalation Therapy methods, Vibration adverse effects
- Abstract
A major symptom of hand-arm vibration syndrome is a secondary Raynaud's phenomenon-vibration white finger (VWF)-which results from a vasospasm of the digital arteries caused by work with vibration devices leading to occupational disease. Pharmacotherapy of VWF is often ineffective or has adverse effects. The aim of this work was to verify the influence of inhalation of partially ionized oxygen (O2•-) on peripheral blood vessels in the hands of patients with VWF. Ninety one (91)patients with VWF underwent four-finger adsorption plethysmography, and the pulse wave amplitude was recorded expressed in numeric parameters-called the native record. Next, a cold water test was conducted following with second plethysmography. The patients were divided in to the three groups. First and second inhaled 20-min of ionized oxygen O2•- or oxygen O2 respectively. Thirth group was control without treatment. All three groups a follow-up third plethysmography-the post-therapy record. Changes in the pulse wave amplitudes were evaluated. Inpatients group inhaling O2•- a modest increase of pulse wave amplitude was observed compared to the native record; patients inhaling medical oxygen O2 and the control showed a undesirable decline of pulse wave amplitude in VWF fingers. Strong vasodilatation were more frequent in the group inhaling O2•- compare to O2 (p < 0.05). Peripheral vasodilatation achieved by inhalation of O2•- could be used for VWF treatment without undesirable side effect in hospital as well as at home environment.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.